| Product NDC: | 62756-529 |
| Proprietary Name: | Desmopressin Acetate |
| Non Proprietary Name: | Desmopressin Acetate |
| Active Ingredient(s): | 4 ug/mL & nbsp; Desmopressin Acetate |
| Administration Route(s): | INTRAVENOUS; SUBCUTANEOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 62756-529 |
| Labeler Name: | Sun Pharmaceutical Industries Limited |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA091280 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20130130 |
| Package NDC: | 62756-529-40 |
| Package Description: | 1 VIAL in 1 CARTON (62756-529-40) > 10 mL in 1 VIAL |
| NDC Code | 62756-529-40 |
| Proprietary Name | Desmopressin Acetate |
| Package Description | 1 VIAL in 1 CARTON (62756-529-40) > 10 mL in 1 VIAL |
| Product NDC | 62756-529 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Desmopressin Acetate |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS; SUBCUTANEOUS |
| Start Marketing Date | 20130130 |
| Marketing Category Name | ANDA |
| Labeler Name | Sun Pharmaceutical Industries Limited |
| Substance Name | DESMOPRESSIN ACETATE |
| Strength Number | 4 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Factor VIII Activator [EPC],Increased Coagulation Factor VIII Activity [PE],Increased Coagulation Factor VIII Concentration [PE],Vasopressin Analog [EPC],Vasopressins [Chemical/Ingredient] |